Journals / Journal of Health Sciences and Medicine / 2026 / Volume: 9 Issue: 4

Clinical outcomes of percutaneous cholecystostomy in high-risk patients with acute cholecystitis

İbrahim Doğan(Department of General Surgery, University of Health Sciences Van Training & Research Hospital)0000-0001-7413-1837
Fırat Canlıkarakaya(Department of General Surgery, University of Amasya)0000-0003-4858-7480
Serhat Ocaklı(Department of General Surgery, Ankara Medipol University Faculty of Medicine)0000-0002-3176-4914
Veysi Gökyer(Department of General Surgery, University of Health Sciences Van Training & Research Hospital)0009-0008-2268-0744
Cengiz Ceylan(Department of General Surgery , Eskişehir City Hospital)0000-0003-3471-8726
Pages
—
Publication Date
2026-07-20
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Aims: Percutaneous cholecystostomy (PC) is recommended for high-risk patients with acute cholecystitis who are unsuitable for early cholecystectomy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: Percutaneous cholecystostomy (PC) is recommended for high-risk patients with acute cholecystitis who are unsuitable for early cholecystectomy.
📊
Key Findings & Data:This study aimed to evaluate short-term clinical outcomes and 30-day mortality in high-risk patients undergoing PC.
💡
Conclusion & Impact:Careful patient selection and structured follow-up strategies are essential to optimize outcomes.
🔬Design:Research Article
📍Scope:2021 Verileri
⚙️Variables:Acute cholecystitis · percutaneous cholecystostomy · high-risk patients

Abstract

Aims: Percutaneous cholecystostomy (PC) is recommended for high-risk patients with acute cholecystitis who are unsuitable for early cholecystectomy. However, clinical outcomes and mortality remain closely linked to patient frailty and comorbidity burden. This study aimed to evaluate short-term clinical outcomes and 30-day mortality in high-risk patients undergoing PC. Methods: This retrospective cohort study included consecutive adult patients who underwent PC for acute cholecystitis at a tertiary care center between 2021 and 2025. Demographic characteristics, comorbidities, Charlson Comorbidity Index (CCI), American Society of Anesthesiologists (ASA) physical status, Tokyo severity grade, clinical presentation, and hospital outcomes were analyzed. The primary endpoint was 30-day mortality. Secondary outcomes included clinical improvement, intensive care unit (ICU) requirement, length of hospital stay, and interval cholecystectomy rate. Results: A total of 55 patients were included (median age 78 years; 53% male). Most patients had Tokyo grade III disease (80%) and high surgical risk (ASA III-IV in 98%). The median CCI was 5 (1-11). Clinical improvement after PC was achieved in 82% of patients. ICU admission was required in 16%, and the median hospital stay was 7 days (4-12). Interval cholecystectomy was performed in 24% of patients, predominantly via a laparoscopic approach (85%). The 30-day mortality rate was 13%. Conclusion: Percutaneous cholecystostomy provides effective acute-phase control in elderly, high-risk patients with acute cholecystitis. However, early mortality remains substantial in this high-risk population, and outcomes should be interpreted within the context of advanced comorbidity burden and severe clinical status. Careful patient selection and structured follow-up strategies are essential to optimize outcomes.

🔖

Cite This Article

Doğan, İ., Canlıkarakaya, F., Ocaklı, S., Gökyer, V., Ceylan, C. (2026). Clinical outcomes of percutaneous cholecystostomy in high-risk patients with acute cholecystitis. Journal of Health Sciences and Medicine, Volume: 9 Issue: 4. https://doi.org/10.32322/jhsm.1910930

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Rimicans M, Fultang J, Thompson L, Oochit K, Maruthachalam K. Outcomes of percutaneous cholecystostomy in the management of acute cholecystitis: a retrospective cohort study at a rural district general hospital. Cureus. 2025;17(10):e95838. doi:10.7759/cureus.95838
  2. Rubio-García JJ, Velilla Vico D, Villodre Tudela C, et al. Impact of percutaneous cholecystostomy in the management of acute cholecystitis: a retrospective cohort study at a tertiary center. Updates Surg. 2023;75(4):905-914. doi:10.1007/s13304-023-01499-3
  3. De Geus T, Moriarty HK, Waters PS, et al. Outcomes of patients treated with upfront cholecystostomy for severe acute cholecystitis. Surg Laparosc Endosc Percutan Tech. 2020;30(1):79-84. doi:10.1097/SLE.0000000000000747
  4. Fanciulli G, Favara G, Maugeri A, Barchitta M, Agodi A, Basile G. Comparing percutaneous treatment and cholecystectomy outcomes in acute cholecystitis patients: a systematic review and meta-analysis. World J Emerg Surg. 2025;20:50. doi:10.1186/s13017-025-00622-6
  5. Gallaher JR, Charles A. Acute cholecystitis: a review. JAMA. 2022; 327(10):965-975. doi:10.1001/jama.2022.2350
  6. Lau J, Sinha S. Outcome predictors of percutaneous cholecystostomy as definitive versus bridging treatment for acute cholecystitis. Cureus. 2023;15(12):e49962. doi:10.7759/cureus.49962
  7. Cirocchi R, Amato L, Ungania S, et al. Management of acute cholecystitis in high-risk patients: percutaneous gallbladder drainage as a definitive treatment vs emergency cholecystectomy-systematic review and meta-analysis. J Clin Med. 2023;12(15):4903. doi:10.3390/jcm12154903
  8. Sadaka AH, Tseng JF, Itani KMF. Indications for and optimal management of percutaneous cholecystostomy drainage: a systematic review. JAMA Surg. 2025;160(12):1368-1377. doi:10.1001/jamasurg.2025.3260
  9. Podder S, Lung K, Ibrahim G, et al. Barriers to interval cholecystectomy following percutaneous cholecystostomy in patients with acute calculous cholecystitis. Surg Endosc. 2025;39(12):8488-8497. doi:10.1007/s00464-025-12161-x
  10. Giannopoulos S, Makhecha K, Madduri S, Garcia F, Baumgartner TC, Stefanidis D. What is the ideal timing of cholecystectomy after percutaneous cholecystostomy for acute cholecystitis? Surg Endosc. 2023;37(11):8764-8770. doi:10.1007/s00464-023-10332-2
  11. Reinsoo A, Kirsimägi Ü, Kibuspuu L, Košeleva K, Lepner U, Talving P. Cholecystostomy tube management in acute cholecystitis: a population-based cohort study. Eur J Trauma Emerg Surg. 2025;51(1):306. doi:10.1007/s00068-025-02972-x
  12. Tuncer K, Kilinc Tuncer G, Çalık B. Factors affecting the recurrence of acute cholecystitis after treatment with percutaneous cholecystostomy. BMC Surg. 2023;23(1):143. doi:10.1186/s12893-023-02042-2
  13. Do YA, Yoon CJ, Lee JH, Choi WS, Lee CH. Percutaneous cholecystostomy as a definitive treatment for acute acalculous cholecystitis: clinical outcomes and risk factors for recurrent cholecystitis. Br J Radiol. 2023; 96(1147):20220943. doi:10.1259/bjr.20220943